Monoamine oxidase A inhibitors

MAOI_A

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N06AG

5119

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

2939

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

2939

diagram downward connector

Include endpoints None

2939

diagram downward connector
MAOI_A

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 2886 1732 1154
Unadjusted prevalence (%) 0.94 1.00 0.85
Mean age at first event (years) 44.11 43.41 45.15

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.20 [0.84, 1.70] 3.1e-1 190
15 years 0.01 0.88 [0.63, 1.23] 4.4e-1 84
5 years 0.00 1.03 [0.65, 1.64] 9.0e-1 22
1 year 0.00 2.64 [1.37, 5.08] 3.7e-3 10

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: MAOI_A – Monoamine oxidase A inhibitors
GWS hits:

Survival analyses between endpoints

Plot

before Monoamine oxidase A inhibitors
after Monoamine oxidase A inhibitors

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Monoamine oxidase A inhibitors